世界の眼炎症治療薬市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Ocular Inflammation Therapeutics Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-5904 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、107ページ • 納品方法：Eメール（納期：3日） • 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥585,000 (USD3,900)	▷ お問い合わせ
Multi User	￥877,500 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査レポートでは、眼炎症治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（コルチコステロイド、抗生物質、モノクローナル抗体、免疫抑制剤、その他）、用途別市場規模（ドラッグストア、病院薬局、オンライン薬局）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・眼炎症治療薬の市場動向 ・企業の競争状況、市場シェア ・眼炎症治療薬の種類別市場規模と予測2016-2027（コルチコステロイド、抗生物質、モノクローナル抗体、免疫抑制剤、その他） ・眼炎症治療薬の用途別市場規模と予測2016-2027（ドラッグストア、病院薬局、オンライン薬局） ・眼炎症治療薬の北米市場規模2016-2027（アメリカ、カナダ） ・眼炎症治療薬の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・眼炎症治療薬のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・眼炎症治療薬の中南米市場規模2016-2027（メキシコ、ブラジル） ・眼炎症治療薬の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Allergan、Cipla、Pfizer、Novartis、Bausch Health、Alimera Sciences、Akorn、Abbvie、Eyegate Pharmaceuticals、pSivida Corporation） ・結論

Ocular inflammation is a component of eye surgery, sometimes leading to its complications, such as macular cystoid edema, and often being targeted by pharmacologic therapy or less invasive surgical procedures.

Market Analysis and Insights: Global Ocular Inflammation Therapeutics Market
The global Ocular Inflammation Therapeutics market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Ocular Inflammation Therapeutics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Ocular Inflammation Therapeutics market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Ocular Inflammation Therapeutics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Ocular Inflammation Therapeutics market.

Global Ocular Inflammation Therapeutics Scope and Market Size
Ocular Inflammation Therapeutics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Ocular Inflammation Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Corticosteroids
Antibiotics
Monoclonal Antibodies
Immunosuppressant
Other

Segment by Application
Drug Stores
Hospital Pharmacies
Online Pharmacies

By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Allergan
Cipla
Pfizer
Novartis
Bausch Health
Alimera Sciences
Akorn
Abbvie
Eyegate Pharmaceuticals
pSivida Corporation

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Ocular Inflammation Therapeutics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Corticosteroids
1.2.3 Antibiotics
1.2.4 Monoclonal Antibodies
1.2.5 Immunosuppressant
1.2.6 Other
1.3 Market by Application
1.3.1 Global Ocular Inflammation Therapeutics Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Drug Stores
1.3.3 Hospital Pharmacies
1.3.4 Online Pharmacies
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Ocular Inflammation Therapeutics Market Perspective (2016-2027)
2.2 Ocular Inflammation Therapeutics Growth Trends by Regions
2.2.1 Ocular Inflammation Therapeutics Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Ocular Inflammation Therapeutics Historic Market Share by Regions (2016-2021)
2.2.3 Ocular Inflammation Therapeutics Forecasted Market Size by Regions (2022-2027)
2.3 Ocular Inflammation Therapeutics Industry Dynamic
2.3.1 Ocular Inflammation Therapeutics Market Trends
2.3.2 Ocular Inflammation Therapeutics Market Drivers
2.3.3 Ocular Inflammation Therapeutics Market Challenges
2.3.4 Ocular Inflammation Therapeutics Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Ocular Inflammation Therapeutics Players by Revenue
3.1.1 Global Top Ocular Inflammation Therapeutics Players by Revenue (2016-2021)
3.1.2 Global Ocular Inflammation Therapeutics Revenue Market Share by Players (2016-2021)
3.2 Global Ocular Inflammation Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Ocular Inflammation Therapeutics Revenue
3.4 Global Ocular Inflammation Therapeutics Market Concentration Ratio
3.4.1 Global Ocular Inflammation Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Ocular Inflammation Therapeutics Revenue in 2020
3.5 Ocular Inflammation Therapeutics Key Players Head office and Area Served
3.6 Key Players Ocular Inflammation Therapeutics Product Solution and Service
3.7 Date of Enter into Ocular Inflammation Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Ocular Inflammation Therapeutics Breakdown Data by Type
4.1 Global Ocular Inflammation Therapeutics Historic Market Size by Type (2016-2021)
4.2 Global Ocular Inflammation Therapeutics Forecasted Market Size by Type (2022-2027)

5 Ocular Inflammation Therapeutics Breakdown Data by Application
5.1 Global Ocular Inflammation Therapeutics Historic Market Size by Application (2016-2021)
5.2 Global Ocular Inflammation Therapeutics Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Ocular Inflammation Therapeutics Market Size (2016-2027)
6.2 North America Ocular Inflammation Therapeutics Market Size by Type
6.2.1 North America Ocular Inflammation Therapeutics Market Size by Type (2016-2021)
6.2.2 North America Ocular Inflammation Therapeutics Market Size by Type (2022-2027)
6.2.3 North America Ocular Inflammation Therapeutics Market Size by Type (2016-2027)
6.3 North America Ocular Inflammation Therapeutics Market Size by Application
6.3.1 North America Ocular Inflammation Therapeutics Market Size by Application (2016-2021)
6.3.2 North America Ocular Inflammation Therapeutics Market Size by Application (2022-2027)
6.3.3 North America Ocular Inflammation Therapeutics Market Size by Application (2016-2027)
6.4 North America Ocular Inflammation Therapeutics Market Size by Country
6.4.1 North America Ocular Inflammation Therapeutics Market Size by Country (2016-2021)
6.4.2 North America Ocular Inflammation Therapeutics Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Ocular Inflammation Therapeutics Market Size (2016-2027)
7.2 Europe Ocular Inflammation Therapeutics Market Size by Type
7.2.1 Europe Ocular Inflammation Therapeutics Market Size by Type (2016-2021)
7.2.2 Europe Ocular Inflammation Therapeutics Market Size by Type (2022-2027)
7.2.3 Europe Ocular Inflammation Therapeutics Market Size by Type (2016-2027)
7.3 Europe Ocular Inflammation Therapeutics Market Size by Application
7.3.1 Europe Ocular Inflammation Therapeutics Market Size by Application (2016-2021)
7.3.2 Europe Ocular Inflammation Therapeutics Market Size by Application (2022-2027)
7.3.3 Europe Ocular Inflammation Therapeutics Market Size by Application (2016-2027)
7.4 Europe Ocular Inflammation Therapeutics Market Size by Country
7.4.1 Europe Ocular Inflammation Therapeutics Market Size by Country (2016-2021)
7.4.2 Europe Ocular Inflammation Therapeutics Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Ocular Inflammation Therapeutics Market Size (2016-2027)
8.2 Asia-Pacific Ocular Inflammation Therapeutics Market Size by Type
8.2.1 Asia-Pacific Ocular Inflammation Therapeutics Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Ocular Inflammation Therapeutics Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Ocular Inflammation Therapeutics Market Size by Type (2016-2027)
8.3 Asia-Pacific Ocular Inflammation Therapeutics Market Size by Application
8.3.1 Asia-Pacific Ocular Inflammation Therapeutics Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Ocular Inflammation Therapeutics Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Ocular Inflammation Therapeutics Market Size by Application (2016-2027)
8.4 Asia-Pacific Ocular Inflammation Therapeutics Market Size by Region
8.4.1 Asia-Pacific Ocular Inflammation Therapeutics Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Ocular Inflammation Therapeutics Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Ocular Inflammation Therapeutics Market Size (2016-2027)
9.2 Latin America Ocular Inflammation Therapeutics Market Size by Type
9.2.1 Latin America Ocular Inflammation Therapeutics Market Size by Type (2016-2021)
9.2.2 Latin America Ocular Inflammation Therapeutics Market Size by Type (2022-2027)
9.2.3 Latin America Ocular Inflammation Therapeutics Market Size by Type (2016-2027)
9.3 Latin America Ocular Inflammation Therapeutics Market Size by Application
9.3.1 Latin America Ocular Inflammation Therapeutics Market Size by Application (2016-2021)
9.3.2 Latin America Ocular Inflammation Therapeutics Market Size by Application (2022-2027)
9.3.3 Latin America Ocular Inflammation Therapeutics Market Size by Application (2016-2027)
9.4 Latin America Ocular Inflammation Therapeutics Market Size by Country
9.4.1 Latin America Ocular Inflammation Therapeutics Market Size by Country (2016-2021)
9.4.2 Latin America Ocular Inflammation Therapeutics Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Ocular Inflammation Therapeutics Market Size (2016-2027)
10.2 Middle East & Africa Ocular Inflammation Therapeutics Market Size by Type
10.2.1 Middle East & Africa Ocular Inflammation Therapeutics Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Ocular Inflammation Therapeutics Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Ocular Inflammation Therapeutics Market Size by Type (2016-2027)
10.3 Middle East & Africa Ocular Inflammation Therapeutics Market Size by Application
10.3.1 Middle East & Africa Ocular Inflammation Therapeutics Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Ocular Inflammation Therapeutics Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Ocular Inflammation Therapeutics Market Size by Application (2016-2027)
10.4 Middle East & Africa Ocular Inflammation Therapeutics Market Size by Country
10.4.1 Middle East & Africa Ocular Inflammation Therapeutics Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Ocular Inflammation Therapeutics Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Allergan
11.1.1 Allergan Company Details
11.1.2 Allergan Business Overview
11.1.3 Allergan Ocular Inflammation Therapeutics Introduction
11.1.4 Allergan Revenue in Ocular Inflammation Therapeutics Business (2016-2021)
11.1.5 Allergan Recent Development
11.2 Cipla
11.2.1 Cipla Company Details
11.2.2 Cipla Business Overview
11.2.3 Cipla Ocular Inflammation Therapeutics Introduction
11.2.4 Cipla Revenue in Ocular Inflammation Therapeutics Business (2016-2021)
11.2.5 Cipla Recent Development
11.3 Pfizer
11.3.1 Pfizer Company Details
11.3.2 Pfizer Business Overview
11.3.3 Pfizer Ocular Inflammation Therapeutics Introduction
11.3.4 Pfizer Revenue in Ocular Inflammation Therapeutics Business (2016-2021)
11.3.5 Pfizer Recent Development
11.4 Novartis
11.4.1 Novartis Company Details
11.4.2 Novartis Business Overview
11.4.3 Novartis Ocular Inflammation Therapeutics Introduction
11.4.4 Novartis Revenue in Ocular Inflammation Therapeutics Business (2016-2021)
11.4.5 Novartis Recent Development
11.5 Bausch Health
11.5.1 Bausch Health Company Details
11.5.2 Bausch Health Business Overview
11.5.3 Bausch Health Ocular Inflammation Therapeutics Introduction
11.5.4 Bausch Health Revenue in Ocular Inflammation Therapeutics Business (2016-2021)
11.5.5 Bausch Health Recent Development
11.6 Alimera Sciences
11.6.1 Alimera Sciences Company Details
11.6.2 Alimera Sciences Business Overview
11.6.3 Alimera Sciences Ocular Inflammation Therapeutics Introduction
11.6.4 Alimera Sciences Revenue in Ocular Inflammation Therapeutics Business (2016-2021)
11.6.5 Alimera Sciences Recent Development
11.7 Akorn
11.7.1 Akorn Company Details
11.7.2 Akorn Business Overview
11.7.3 Akorn Ocular Inflammation Therapeutics Introduction
11.7.4 Akorn Revenue in Ocular Inflammation Therapeutics Business (2016-2021)
11.7.5 Akorn Recent Development
11.8 Abbvie
11.8.1 Abbvie Company Details
11.8.2 Abbvie Business Overview
11.8.3 Abbvie Ocular Inflammation Therapeutics Introduction
11.8.4 Abbvie Revenue in Ocular Inflammation Therapeutics Business (2016-2021)
11.8.5 Abbvie Recent Development
11.9 Eyegate Pharmaceuticals
11.9.1 Eyegate Pharmaceuticals Company Details
11.9.2 Eyegate Pharmaceuticals Business Overview
11.9.3 Eyegate Pharmaceuticals Ocular Inflammation Therapeutics Introduction
11.9.4 Eyegate Pharmaceuticals Revenue in Ocular Inflammation Therapeutics Business (2016-2021)
11.9.5 Eyegate Pharmaceuticals Recent Development
11.10 pSivida Corporation
11.10.1 pSivida Corporation Company Details
11.10.2 pSivida Corporation Business Overview
11.10.3 pSivida Corporation Ocular Inflammation Therapeutics Introduction
11.10.4 pSivida Corporation Revenue in Ocular Inflammation Therapeutics Business (2016-2021)
11.10.5 pSivida Corporation Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Ocular Inflammation Therapeutics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Corticosteroids
Table 3. Key Players of Antibiotics
Table 4. Key Players of Monoclonal Antibodies
Table 5. Key Players of Immunosuppressant
Table 6. Key Players of Other
Table 7. Global Ocular Inflammation Therapeutics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Ocular Inflammation Therapeutics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Ocular Inflammation Therapeutics Market Size by Regions (2016-2021) & (US$ Million)
Table 10. Global Ocular Inflammation Therapeutics Market Share by Regions (2016-2021)
Table 11. Global Ocular Inflammation Therapeutics Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 12. Global Ocular Inflammation Therapeutics Market Share by Regions (2022-2027)
Table 13. Ocular Inflammation Therapeutics Market Trends
Table 14. Ocular Inflammation Therapeutics Market Drivers
Table 15. Ocular Inflammation Therapeutics Market Challenges
Table 16. Ocular Inflammation Therapeutics Market Restraints
Table 17. Global Ocular Inflammation Therapeutics Revenue by Players (2016-2021) & (US$ Million)
Table 18. Global Ocular Inflammation Therapeutics Market Share by Players (2016-2021)
Table 19. Global Top Ocular Inflammation Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Ocular Inflammation Therapeutics as of 2020)
Table 20. Ranking of Global Top Ocular Inflammation Therapeutics Companies by Revenue (US$ Million) in 2020
Table 21. Global 5 Largest Players Market Share by Ocular Inflammation Therapeutics Revenue (CR5 and HHI) & (2016-2021)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Ocular Inflammation Therapeutics Product Solution and Service
Table 24. Date of Enter into Ocular Inflammation Therapeutics Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Ocular Inflammation Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 27. Global Ocular Inflammation Therapeutics Revenue Market Share by Type (2016-2021)
Table 28. Global Ocular Inflammation Therapeutics Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 29. Global Ocular Inflammation Therapeutics Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 30. Global Ocular Inflammation Therapeutics Market Size Share by Application (2016-2021) & (US$ Million)
Table 31. Global Ocular Inflammation Therapeutics Revenue Market Share by Application (2016-2021)
Table 32. Global Ocular Inflammation Therapeutics Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 33. Global Ocular Inflammation Therapeutics Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 34. North America Ocular Inflammation Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 35. North America Ocular Inflammation Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 36. North America Ocular Inflammation Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 37. North America Ocular Inflammation Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 38. North America Ocular Inflammation Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 39. North America Ocular Inflammation Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 40. Europe Ocular Inflammation Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 41. Europe Ocular Inflammation Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 42. Europe Ocular Inflammation Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 43. Europe Ocular Inflammation Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 44. Europe Ocular Inflammation Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 45. Europe Ocular Inflammation Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Ocular Inflammation Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 47. Asia-Pacific Ocular Inflammation Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Ocular Inflammation Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 49. Asia-Pacific Ocular Inflammation Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 50. Asia-Pacific Ocular Inflammation Therapeutics Market Size by Region (2016-2021) & (US$ Million)
Table 51. Asia-Pacific Ocular Inflammation Therapeutics Market Size by Region (2022-2027) & (US$ Million)
Table 52. Latin America Ocular Inflammation Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 53. Latin America Ocular Inflammation Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 54. Latin America Ocular Inflammation Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 55. Latin America Ocular Inflammation Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 56. Latin America Ocular Inflammation Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 57. Latin America Ocular Inflammation Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Ocular Inflammation Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 59. Middle East & Africa Ocular Inflammation Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Ocular Inflammation Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 61. Middle East & Africa Ocular Inflammation Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 62. Middle East & Africa Ocular Inflammation Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 63. Middle East & Africa Ocular Inflammation Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 64. Allergan Company Details
Table 65. Allergan Business Overview
Table 66. Allergan Ocular Inflammation Therapeutics Product
Table 67. Allergan Revenue in Ocular Inflammation Therapeutics Business (2016-2021) & (US$ Million)
Table 68. Allergan Recent Development
Table 69. Cipla Company Details
Table 70. Cipla Business Overview
Table 71. Cipla Ocular Inflammation Therapeutics Product
Table 72. Cipla Revenue in Ocular Inflammation Therapeutics Business (2016-2021) & (US$ Million)
Table 73. Cipla Recent Development
Table 74. Pfizer Company Details
Table 75. Pfizer Business Overview
Table 76. Pfizer Ocular Inflammation Therapeutics Product
Table 77. Pfizer Revenue in Ocular Inflammation Therapeutics Business (2016-2021) & (US$ Million)
Table 78. Pfizer Recent Development
Table 79. Novartis Company Details
Table 80. Novartis Business Overview
Table 81. Novartis Ocular Inflammation Therapeutics Product
Table 82. Novartis Revenue in Ocular Inflammation Therapeutics Business (2016-2021) & (US$ Million)
Table 83. Novartis Recent Development
Table 84. Bausch Health Company Details
Table 85. Bausch Health Business Overview
Table 86. Bausch Health Ocular Inflammation Therapeutics Product
Table 87. Bausch Health Revenue in Ocular Inflammation Therapeutics Business (2016-2021) & (US$ Million)
Table 88. Bausch Health Recent Development
Table 89. Alimera Sciences Company Details
Table 90. Alimera Sciences Business Overview
Table 91. Alimera Sciences Ocular Inflammation Therapeutics Product
Table 92. Alimera Sciences Revenue in Ocular Inflammation Therapeutics Business (2016-2021) & (US$ Million)
Table 93. Alimera Sciences Recent Development
Table 94. Akorn Company Details
Table 95. Akorn Business Overview
Table 96. Akorn Ocular Inflammation Therapeutics Product
Table 97. Akorn Revenue in Ocular Inflammation Therapeutics Business (2016-2021) & (US$ Million)
Table 98. Akorn Recent Development
Table 99. Abbvie Company Details
Table 100. Abbvie Business Overview
Table 101. Abbvie Revenue in Ocular Inflammation Therapeutics Business (2016-2021) & (US$ Million)
Table 102. Abbvie Recent Development
Table 103. Eyegate Pharmaceuticals Company Details
Table 104. Eyegate Pharmaceuticals Business Overview
Table 105. Eyegate Pharmaceuticals Ocular Inflammation Therapeutics Product
Table 106. Eyegate Pharmaceuticals Revenue in Ocular Inflammation Therapeutics Business (2016-2021) & (US$ Million)
Table 107. Eyegate Pharmaceuticals Recent Development
Table 108. pSivida Corporation Company Details
Table 109. pSivida Corporation Business Overview
Table 110. pSivida Corporation Ocular Inflammation Therapeutics Product
Table 111. pSivida Corporation Revenue in Ocular Inflammation Therapeutics Business (2016-2021) & (US$ Million)
Table 112. pSivida Corporation Recent Development
Table 113. Research Programs/Design for This Report
Table 114. Key Data Information from Secondary Sources
Table 115. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Ocular Inflammation Therapeutics Market Share by Type: 2020 VS 2027
Figure 2. Corticosteroids Features
Figure 3. Antibiotics Features
Figure 4. Monoclonal Antibodies Features
Figure 5. Immunosuppressant Features
Figure 6. Other Features
Figure 7. Global Ocular Inflammation Therapeutics Market Share by Application: 2020 VS 2027
Figure 8. Drug Stores Case Studies
Figure 9. Hospital Pharmacies Case Studies
Figure 10. Online Pharmacies Case Studies
Figure 11. Ocular Inflammation Therapeutics Report Years Considered
Figure 12. Global Ocular Inflammation Therapeutics Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 13. Global Ocular Inflammation Therapeutics Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global Ocular Inflammation Therapeutics Market Share by Regions: 2020 VS 2027
Figure 15. Global Ocular Inflammation Therapeutics Market Share by Regions (2022-2027)
Figure 16. Global Ocular Inflammation Therapeutics Market Share by Players in 2020
Figure 17. Global Top Ocular Inflammation Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Ocular Inflammation Therapeutics as of 2020
Figure 18. The Top 10 and 5 Players Market Share by Ocular Inflammation Therapeutics Revenue in 2020
Figure 19. Global Ocular Inflammation Therapeutics Revenue Market Share by Type (2016-2021)
Figure 20. Global Ocular Inflammation Therapeutics Revenue Market Share by Type (2022-2027)
Figure 21. North America Ocular Inflammation Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. North America Ocular Inflammation Therapeutics Market Share by Type (2016-2027)
Figure 23. North America Ocular Inflammation Therapeutics Market Share by Application (2016-2027)
Figure 24. North America Ocular Inflammation Therapeutics Market Share by Country (2016-2027)
Figure 25. United States Ocular Inflammation Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Canada Ocular Inflammation Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Ocular Inflammation Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Ocular Inflammation Therapeutics Market Share by Type (2016-2027)
Figure 29. Europe Ocular Inflammation Therapeutics Market Share by Application (2016-2027)
Figure 30. Europe Ocular Inflammation Therapeutics Market Share by Country (2016-2027)
Figure 31. Germany Ocular Inflammation Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. France Ocular Inflammation Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. U.K. Ocular Inflammation Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Italy Ocular Inflammation Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Russia Ocular Inflammation Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Nordic Ocular Inflammation Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Ocular Inflammation Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Ocular Inflammation Therapeutics Market Share by Type (2016-2027)
Figure 39. Asia-Pacific Ocular Inflammation Therapeutics Market Share by Application (2016-2027)
Figure 40. Asia-Pacific Ocular Inflammation Therapeutics Market Share by Region (2016-2027)
Figure 41. China Ocular Inflammation Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Japan Ocular Inflammation Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. South Korea Ocular Inflammation Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Southeast Asia Ocular Inflammation Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. India Ocular Inflammation Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Australia Ocular Inflammation Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Ocular Inflammation Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Ocular Inflammation Therapeutics Market Share by Type (2016-2027)
Figure 49. Latin America Ocular Inflammation Therapeutics Market Share by Application (2016-2027)
Figure 50. Latin America Ocular Inflammation Therapeutics Market Share by Country (2016-2027)
Figure 51. Mexico Ocular Inflammation Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Brazil Ocular Inflammation Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Ocular Inflammation Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Ocular Inflammation Therapeutics Market Share by Type (2016-2027)
Figure 55. Middle East & Africa Ocular Inflammation Therapeutics Market Share by Application (2016-2027)
Figure 56. Middle East & Africa Ocular Inflammation Therapeutics Market Share by Country (2016-2027)
Figure 57. Turkey Ocular Inflammation Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Saudi Arabia Ocular Inflammation Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. UAE Ocular Inflammation Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. Allergan Revenue Growth Rate in Ocular Inflammation Therapeutics Business (2016-2021)
Figure 61. Cipla Revenue Growth Rate in Ocular Inflammation Therapeutics Business (2016-2021)
Figure 62. Pfizer Revenue Growth Rate in Ocular Inflammation Therapeutics Business (2016-2021)
Figure 63. Novartis Revenue Growth Rate in Ocular Inflammation Therapeutics Business (2016-2021)
Figure 64. Bausch Health Revenue Growth Rate in Ocular Inflammation Therapeutics Business (2016-2021)
Figure 65. Alimera Sciences Revenue Growth Rate in Ocular Inflammation Therapeutics Business (2016-2021)
Figure 66. Akorn Revenue Growth Rate in Ocular Inflammation Therapeutics Business (2016-2021)
Figure 67. Abbvie Revenue Growth Rate in Ocular Inflammation Therapeutics Business (2016-2021)
Figure 68. Eyegate Pharmaceuticals Revenue Growth Rate in Ocular Inflammation Therapeutics Business (2016-2021)
Figure 69. pSivida Corporation Revenue Growth Rate in Ocular Inflammation Therapeutics Business (2016-2021)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed

---